The Involvement of ATP-sensitive Potassium Channels in Beta-adrenoceptor-mediated Vasorelaxation in the Rat Isolated Mesenteric Arterial Bed

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1995 Jun 1

PMID 7582479

Citations 21

Authors

M D Randall

A I McCulloch

Affiliations

Soon will be listed here.

Abstract

1. We have used the isolated buffer-perfused superior mesenteric arterial bed of the rat to assess the involvement of ATP-sensitive potassium (KATP) channels in the vasorelaxant responses to beta-adrenoceptor agonists. 2. The vasorelaxant potencies of the non-selective beta-adrenoceptor agonist, isoprenaline, the beta 1-adrenoceptor agonist, dobutamine and the beta 2-adrenoceptor agonist, terbutaline were all significantly (P < 0.05) reduced (isoprenaline, ED50 = 265 +/- 31 pmol v. 1.05 +/- 0.42 nmol; dobutamine, ED50 = 294 +/- 67 pmol v. 497 +/- 115 pmol; terbutaline, ED50 = 157 +/- 26 nmol v. 452 +/- 120 nmol) in the presence of the KATP-channel blocker, glibenclamide. 3. The presence of glibenclamide only weakly influenced the vasorelaxant properties of salbutamol, a beta 2-adrenoceptor agonist, while those of verapamil, a beta-adrenoceptor-independent vasorelaxant, were unaffected. 4. In radioligand binding experiments, glibenclamide (1 nM-100 microM) did not displace any specific [3H]-dihydroalprenolol binding from rat beta-adrenoceptors. Therefore, glibenclamide does not bind to beta-adrenoceptors at the concentration used in the present investigation. 5. Vasorelaxant responses to dibutyryl cyclic AMP, the cell permeable analogue of cyclic AMP, were also unaffected by glibenclamide, indicating that the coupling of beta-adrenoceptors to KATP-channels occurs independently of the elevation of intracellular cyclic AMP. 6. We have shown that a significant element of the vasorelaxant responses to both beta 1- and beta 2-adrenoceptor activation involves the opening of KATP-channels. In conclusion, KATP-channels may play a physiological role in beta-adrenoceptor-mediated vasodilatation.

Citing Articles

Investigating the Role of G Protein βγ in Kv7-Dependent Relaxations of the Rat Vasculature.

Stott J, Barrese V, Suresh M, Masoodi S, Greenwood I Arterioscler Thromb Vasc Biol. 2018; 38(9):2091-2102.

PMID: 30002060 PMC: 6173295. DOI: 10.1161/ATVBAHA.118.311360.

Kv7 Channel Activation Underpins EPAC-Dependent Relaxations of Rat Arteries.

Stott J, Barrese V, Greenwood I Arterioscler Thromb Vasc Biol. 2016; 36(12):2404-2411.

PMID: 27789473 PMC: 5467728. DOI: 10.1161/ATVBAHA.116.308517.

ATP-sensitive potassium channels modulate in vitro tocolytic effects of β₂-adrenergic receptor agonists on uterine muscle rings in rats in early but not in late pregnancy.

Lovasz N, Koncz A, Domokos D, Gaspar R, Falkay G Croat Med J. 2015; 56(2):114-8.

PMID: 25891870 PMC: 4410172. DOI: 10.3325/cmj.2015.56.114.

Vasodilatory mechanisms of beta receptor blockade.

Rath G, Balligand J, Dessy C, Chantal D Curr Hypertens Rep. 2012; 14(4):310-7.

PMID: 22639015 DOI: 10.1007/s11906-012-0278-3.

Impaired β-adrenoceptor-induced relaxation in small mesenteric arteries from DOCA-salt hypertensive rats is due to reduced K(Ca) channel activity.

Matsumoto T, Szasz T, Tostes R, Webb R Pharmacol Res. 2012; 65(5):537-45.

PMID: 22388053 PMC: 3327799. DOI: 10.1016/j.phrs.2012.02.004.

References

Kroeger E, Marshall J . Beta-adrenergic effects on rat myometrium: mechanisms of membrane hyperpolarization. Am J Physiol. 1973; 225(6):1339-45. DOI: 10.1152/ajplegacy.1973.225.6.1339. View

Schackow T, Ten Eick R . Enhancement of ATP-sensitive potassium current in cat ventricular myocytes by beta-adrenoreceptor stimulation. J Physiol. 1994; 474(1):131-45. PMC: 1160301. DOI: 10.1113/jphysiol.1994.sp020008. View

Sturgess N, Ashford M, Cook D, Hales C . The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet. 1985; 2(8453):474-5. DOI: 10.1016/s0140-6736(85)90403-9. View

Brown A, Birnbaumer L . Direct G protein gating of ion channels. Am J Physiol. 1988; 254(3 Pt 2):H401-10. DOI: 10.1152/ajpheart.1988.254.3.H401. View

Chamienia A, Johns E . The renal functional responses to 5-HT1A receptor agonist, flesinoxan, in anaesthetized, normotensive rat. Br J Pharmacol. 1994; 112(1):214-8. PMC: 1910283. DOI: 10.1111/j.1476-5381.1994.tb13054.x. View

Bouchard J, Dumont E, Lamontagne D . Evidence that prostaglandins I2, E2, and D2 may activate ATP sensitive potassium channels in the isolated rat heart. Cardiovasc Res. 1994; 28(6):901-5. DOI: 10.1093/cvr/28.6.901. View

Torphy T . Beta-adrenoceptors, cAMP and airway smooth muscle relaxation: challenges to the dogma. Trends Pharmacol Sci. 1994; 15(10):370-4. DOI: 10.1016/0165-6147(94)90157-0. View

Nakashima M, Vanhoutte P . Isoproterenol causes hyperpolarization through opening of ATP-sensitive potassium channels in vascular smooth muscle of the canine saphenous vein. J Pharmacol Exp Ther. 1995; 272(1):379-84. View

Randall M, Hiley C . Effect of phenobarbitone pretreatment upon endothelium-dependent relaxation to acetylcholine in rat superior mesenteric arterial bed. Br J Pharmacol. 1988; 94(3):977-83. PMC: 1854023. DOI: 10.1111/j.1476-5381.1988.tb11612.x. View

10.

Standen N, Quayle J, Davies N, Brayden J, Huang Y, Nelson M . Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989; 245(4914):177-80. DOI: 10.1126/science.2501869. View

11.

Ribalet B, Ciani S, Eddlestone G . ATP mediates both activation and inhibition of K(ATP) channel activity via cAMP-dependent protein kinase in insulin-secreting cell lines. J Gen Physiol. 1989; 94(4):693-717. PMC: 2228969. DOI: 10.1085/jgp.94.4.693. View

12.

Nelson M, Huang Y, Brayden J, Hescheler J, Standen N . Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature. 1990; 344(6268):770-3. DOI: 10.1038/344770a0. View

13.

Kirsch G, CODINA J, Birnbaumer L, Brown A . Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol. 1990; 259(3 Pt 2):H820-6. DOI: 10.1152/ajpheart.1990.259.3.H820. View

14.

Edwards G, Weston A . Potassium channel openers and vascular smooth muscle relaxation. Pharmacol Ther. 1990; 48(2):237-58. DOI: 10.1016/0163-7258(90)90082-d. View

15.

Nichols C, Lederer W . Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol. 1991; 261(6 Pt 2):H1675-86. DOI: 10.1152/ajpheart.1991.261.6.H1675. View

16.

Merkel L, Lappe R, Rivera L, Cox B, Perrone M . Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels. J Pharmacol Exp Ther. 1992; 260(2):437-43. View

17.

DOWNING S, Hollingsworth M . One way cross tolerance between cromakalim and salbutamol in the uterus of the rat in vivo. Br J Pharmacol. 1992; 105(1):129-34. PMC: 1908624. DOI: 10.1111/j.1476-5381.1992.tb14223.x. View

18.

Miura M, Belvisi M, Stretton C, Yacoub M, Barnes P . Role of potassium channels in bronchodilator responses in human airways. Am Rev Respir Dis. 1992; 146(1):132-6. DOI: 10.1164/ajrccm/146.1.132. View

19.

Kitazono T, Faraci F, Heistad D . Effect of norepinephrine on rat basilar artery in vivo. Am J Physiol. 1993; 264(1 Pt 2):H178-82. DOI: 10.1152/ajpheart.1993.264.1.H178. View

20.

Randall M, Griffith T . Modulation of vasodilatation to levcromakalim by hypoxia and EDRF in the rabbit isolated ear: a comparison with pinacidil, sodium nitroprusside and verapamil. Br J Pharmacol. 1993; 109(2):386-93. PMC: 2175711. DOI: 10.1111/j.1476-5381.1993.tb13581.x. View